Potentiation by deprenyl of the autoreceptor-mediated inhibition of [3H]-5-hydroxytryptamine release by 5-methoxytryptamine

Naunyn Schmiedebergs Arch Pharmacol. 1986 Jul;333(3):330-3. doi: 10.1007/BF00512949.

Abstract

The 5-hydroxytryptamine (5HT) receptor agonist, 5-methoxytryptamine, inhibited in a concentration-dependent manner the electrically-evoked release of 3H-5HT from superfused rat hypothalamic slices, with an IC50 of 560 nmol/l, without affecting the spontaneous outflow of radioactivity. In the presence of the selective monoamine oxidase B (MAO B) inhibitor, (-)-deprenyl (1 mumol/l), the concentration-effect curve for 5-methoxytryptamine was shifted significantly to the left, and the IC50 was decreased to 25 nmol/l. Under the same experimental conditions, the potency of the 5HT receptor agonist lysergic acid diethylamide (LSD) at inhibiting the electrically-evoked release of 3H-5HT was the same in the presence as well as in the absence of (-)-deprenyl. The IC50 values for LSD were 34 nmol/l in the absence of deprenyl, and 31 nmol/l in the presence of the MAO B inhibitor. It is concluded that deprenyl potentiates the inhibition by 5-methoxytryptamine of 3H-5HT release, by preventing its inactivation through MAO B. Since 5-methoxytryptamine may be present in the pineal gland of some species, the potent effects of this 5-HT receptor agonist on serotoninergic neurotransmission may be of physiological relevance.

MeSH terms

  • 5-Methoxytryptamine / pharmacology*
  • Animals
  • Electric Stimulation
  • Hypothalamus / drug effects
  • Hypothalamus / physiology
  • In Vitro Techniques
  • Lysergic Acid Diethylamide / pharmacology
  • Male
  • Phenethylamines / pharmacology*
  • Rats
  • Rats, Inbred Strains
  • Receptors, Serotonin / drug effects*
  • Selegiline / pharmacology*
  • Serotonin / metabolism*
  • Tryptamines / pharmacology*

Substances

  • Phenethylamines
  • Receptors, Serotonin
  • Tryptamines
  • Selegiline
  • Serotonin
  • 5-Methoxytryptamine
  • Lysergic Acid Diethylamide